Cathepsin D regulates lipid metabolism in murine steatohepatitis
Abstract Due to the obesity epidemic, non-alcoholic steatohepatitis (NASH) is a prevalent liver disease, characterized by fat accumulation and inflammation of the liver. However, due to a lack of mechanistic insight, diagnostic and therapeutic options for NASH are poor. Recent evidence has indicated...
Guardado en:
Autores principales: | Tom Houben, Yvonne Oligschlaeger, Tim Hendrikx, Albert V. Bitorina, Sofie M. A. Walenbergh, Patrick J. van Gorp, Marion J. J. Gijbels, Silvia Friedrichs, Jogchum Plat, Frank G. Schaap, Dieter Lütjohann, Marten H. Hofker, Ronit Shiri-Sverdlov |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cfb2f1134c3242eca9f6af53a9707ebd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
por: Feroz Ahmad, et al.
Publicado: (2021) -
Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults
por: Peter J. Joris, et al.
Publicado: (2017) -
Therapeutic potential of targeting cathepsin S in pulmonary fibrosis
por: YoungJo Yoo, et al.
Publicado: (2022) -
One-year daily consumption of buttermilk drink containing lutein-enriched egg-yolks does not affect endothelial function in fasting and postprandial state
por: Sanne M. van der Made, et al.
Publicado: (2017) -
Statins in Non-alcoholic Steatohepatitis
por: Jose D. Torres-Peña, et al.
Publicado: (2021)